Please login to the form below

Not currently logged in
Email:
Password:

bitopertin

This page shows the latest bitopertin news and features for those working in and with pharma, biotech and healthcare.

Abilify Maintena launches in Europe

Abilify Maintena launches in Europe

Prospects for drugs that tackle the latter remain up in the air, however; Roche's bitopertin was leading the field but generated poor results in two phase III trials reported earlier

Latest news

  • Setback for Roche as schizophrenia candidate fails studies Setback for Roche as schizophrenia candidate fails studies

    Like bitopertin both of these were being tested as add-on drugs to tackle negative symptoms, but had different mechanisms of action. ... Analysts have suggested in the past that bitopertin could achieve sales of $3bn or more if it proves effective in

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics